semaglutide receptor – the Surprising New Anti-Fibrosis Drug Semaglutide Research Peptide: GLP-1R Scientific

Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure

BMC Biol 23 , 263 (2025)

The decision to combine these medications should always be made collaboratively between the patient and their healthcare provider, taking into account the patient's complete medical history, current symptom control, and treatment goals

Data Availability Statement The raw data supporting the conclusions of this article will be made available by the authors upon request

Embryonal erythropoiesis and aging exploit ferroptosis

In a placebo-controlled randomized trial, adults with obesity and alcohol use disorder had a greater drop in heavy drinking days with semaglutide